Literature DB >> 28236058

Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation.

Atsushi Yamashita1, Tsuyoshi Saito2, Keisuke Akaike1,3, Atsushi Arakawa1, Akihiko Yoshida4, Kentaro Kikuchi5,6, Masahiko Sugitani5, Takashi Yao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28236058     DOI： 10.1007/s00428-017-2089-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  22 in total

1.  Mast cell sarcoma mimicking metastatic colon carcinoma.

Authors:  Juliana Schwaab; Hans Peter Horny; Jens Jonescheit; Georgia Metzgeroth; Philippe Schafhausen; Timo Gaiser; Alexander Marx; Peter Kienle; Wolf Karsten Hofmann; Andreas Reiter
Journal:  Ann Hematol       Date:  2013-10-19       Impact factor: 3.673

2.  Mast cell sarcoma of the small intestine: a case report.

Authors:  Amit Bugalia; Aby Abraham; Poonkuzhali Balasubramanian; Alok Srivastava; Sheila Nair
Journal:  J Clin Pathol       Date:  2011-07-21       Impact factor: 3.411

3.  FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.

Authors:  S Djelbani-Ahmed; M O Chandesris; A Mekinian; D Canioni; C Brouzes; K Hanssens; G Pop; I Durieu; S Durupt; B Grosbois; S Besnard; O Tournilhac; O Beyne-Rauzy; P Agapé; A Delmer; D Ranta; P Y Jeandel; S Georgin-Lavialle; L Frenzel; G Damaj; V Eder; O Lortholary; O Hermine; O Fain; M Soussan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-05       Impact factor: 9.236

Review 4.  The role of KIT in the management of patients with gastrointestinal stromal tumors.

Authors:  Jason L Hornick; Christopher D M Fletcher
Journal:  Hum Pathol       Date:  2007-05       Impact factor: 3.466

5.  Mast cell sarcoma with tissue eosinophilia arising in the ascending colon.

Authors:  M Kojima; S Nakamura; H Itoh; Y Ohno; N Masawa; T Joshita; T Suchi
Journal:  Mod Pathol       Date:  1999-07       Impact factor: 7.842

6.  Successful treatment of mast cell sarcoma of the uterus with imatinib.

Authors:  Hong Bing Ma; Xia Xu; Wei Ping Liu; Hong Chang; Fan Zeng; Yu Chun Wang
Journal:  Int J Hematol       Date:  2011-10-22       Impact factor: 2.490

7.  Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm.

Authors:  Young S Kim; Huiqing Wu; Anna B Pawlowska; Marnelli A Bautista-Quach; Qin Huang; Karl Gaal; Karen L Chang
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

8.  A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors.

Authors:  M Nakahara; K Isozaki; S Hirota; J Miyagawa; N Hase-Sawada; M Taniguchi; T Nishida; S Kanayama; Y Kitamura; Y Shinomura; Y Matsuzawa
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

9.  Clinicopathological effects of protein phosphatase 2, regulatory subunit A, alpha mutations in gastrointestinal stromal tumors.

Authors:  Midori Toda-Ishii; Keisuke Akaike; Yoshiyuki Suehara; Kenta Mukaihara; Daisuke Kubota; Shinji Kohsaka; Taketo Okubo; Keiko Mitani; Kaoru Mogushi; Tatsuya Takagi; Kazuo Kaneko; Takashi Yao; Tsuyoshi Saito
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

10.  Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor.

Authors:  Eric P Kleinbaum; Alexander J F Lazar; Elena Tamborini; John C Mcauliffe; Pamela B Sylvestre; Thomas D Sunnenberg; Louise Strong; Lei L Chen; Haesun Choi; Robert S Benjamin; Wei Zhang; Jonathan C Trent
Journal:  Int J Cancer       Date:  2008-02-01       Impact factor: 7.396
View more
  4 in total

1.  Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016.

Authors:  Akiko Miyagi Maeshima; Hirokazu Taniguchi; Tomotaka Suzuki; Sayako Yuda; Kosuke Toyoda; Nobuhiko Yamauchi; Shinichi Makita; Suguru Fukuhara; Wataru Munakata; Dai Maruyama; Yukio Kobayashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2017-09-18       Impact factor: 2.490

2.  HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.

Authors:  Li Xiong; Shuqing Zhen; Qionghua Yu; Zuojiong Gong
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

Review 3.  Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma.

Authors:  Wenbing Sun; Shuqi Fu; Size Wu; Rong Tu
Journal:  Biomed Res Int       Date:  2020-11-27       Impact factor: 3.411

Review 4.  Exploring the role of mast cells in the progression of liver disease.

Authors:  Shizhuan Huang; Haotian Wu; Feng Luo; Bin Zhang; Tianwei Li; Zongrui Yang; Bixuan Ren; Wenze Yin; Dehai Wu; Sheng Tai
Journal:  Front Physiol       Date:  2022-09-13       Impact factor: 4.755
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.